The decrease of complication rate in hypertensives: Benefits of combined antihypertensive treatment by Perindopril and Amlodipine (adapted from the materials from the Annual Scientific Meeting of the European Society of Hypertension [ESH], 2011)
Effective blood pressure (BP) control remains a key factor in the reduction of cardiovascular morbidity and mortality. Main criteria of choice of rational antihypertensive therapy include optimal antihypertensive effect and documented reduction of the risk of cardiovascular events and mortality. On 18<sup>th</sup> June, 2011, at the European Meeting on Hypertension and Cardiovascular Prevention, the symposium «Is hypertension a fatal disease today?» was held with discussions on the effective antihypertensive therapy in hypertensive patients using fixed-dose combination of perindopril and amlodipine (Prestance). This treatment can be recommended as preferable for hypertensive patients with uncontrolled BP, with high risk of complications, with diabetes mellitus and coronary heart disease.